title: Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
abstract: UGP, the beta-core fragment of human chorionic gonadotropin has been proposed as a tumor marker for gynecological malignancies. This fragment may be detected in a single morning-specimen of urine using an enzyme immunoassay. In this study, the diagnostic usefulness of urine UGP and serum CA 125 measurement for gynecological neoplasias (149 cases) was evaluated using a control group of patients with benign gynecological diseases (69 cases) and healthy females (99 cases). Considering the neoplastic patients in comparison to patients with benign diseases, the best diagnostic efficiency (78%) was found to correspond to a cut-off level of 120 pmol/mol creatinine the sensitivity being 73% and the specificity 90%. With this cut-off, an efficiency of 82% for healthy controls was obtained. Since the menopausal condition increases UGP levels, and though no significant difference for UGP was found between healthy subjects and patients with benign diseases, we decided to consider the reference populations as a single group. Thus, we evaluated the UGP performance on the basis of menopausal status. When a specificity of 95% was fixed, the cut-off values were 120 and 180 pmol/mol creatinine for pre- and postmenopausal women respectively, the sensitivity being 73% and 64%. Finally the combined evaluation of UGP and CA 125 improved their individual clinical efficiency for the diagnosis of ovarian serous cystadenocarcinomas, assuring a sensitivity of 86% and a specificity of 89%.
authors.affiliation: Department of Laboratory Medicine, University-Hospital of Padova, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Plebani
authors.forename: F
authors.initials: F
authors.lastname: Navaglia
authors.forename: D
authors.initials: D
authors.lastname: Basso
authors.forename: M
authors.initials: M
authors.lastname: De Paoli
authors.forename: M O
authors.initials: MO
authors.lastname: Nicoletto
authors.forename: E
authors.initials: E
authors.lastname: Maraglino
authors.forename: G C
authors.initials: GC
authors.lastname: Torre
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood* / Q000652:urine*; D018394:CA-125 Antigen / Q000097:blood*; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000652:urine*; D003937:Diagnosis, Differential; D005260:Female; D005831:Genital Diseases, Female / Q000097:blood / Q000652:urine; D005833:Genital Neoplasms, Female / Q000097:blood* / Q000175:diagnosis / Q000652:urine*; D006801:Humans; D008875:Middle Aged; D010446:Peptide Fragments / Q000652:urine*
chemical_list: D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D018997:Chorionic Gonadotropin, beta Subunit, Human; D010446:Peptide Fragments; C063554:urinary gonadotropin fragment